Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients

From BugSigDB
Reviewed Marked as Reviewed by Svetlana up on 2024-6-5
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Hu X, Wang H, Yu B, Yu J, Lu H, Sun J, Sun Y, Zou Y, Luo H, Zeng Z, Liu S, Jiang Y, Wu Z, Ren Z
Journal
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Year
2023
Keywords:
coronavirus disease 2019, mycobiome, non-invasive biomarkers, oral fungi, severe acute respiratory syndrome coronavirus 2
The oral bacteriome, gut bacteriome, and gut mycobiome are associated with coronavirus disease 2019 (COVID-19). However, the oral fungal microbiota in COVID-19 remains unclear. This article aims to characterize the oral mycobiome in COVID-19 and recovered patients. Tongue coating specimens of 71 COVID-19 patients, 36 suspected cases (SCs), 22 recovered COVID-19 patients, 36 SCs who recovered, and 132 controls from Henan are collected and analyzed using internal transcribed spacer sequencing. The richness of oral fungi is increased in COVID-19 versus controls, and beta diversity analysis reveals separate fungal communities for COVID-19 and control. The ratio of Ascomycota and Basidiomycota is higher in COVID-19, and the opportunistic pathogens, including the genera Candida, Saccharomyces, and Simplicillium, are increased in COVID-19. The classifier based on two fungal biomarkers is constructed and can distinguish COVID-19 patients from controls in the training, testing, and independent cohorts. Importantly, the classifier successfully diagnoses SCs with positive specific severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies as COVID-19 patients. The correlation between distinct fungi and bacteria in COVID-19 and control groups is depicted. These data suggest that the oral mycobiome may play a role in COVID-19.

Experiment 1


Reviewed Marked as Reviewed by Svetlana up on 2024-6-5

Curated date: 2024/04/18

Curator: Victoria

Revision editor(s): Victoria

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Surface of tongue Tongue surface,Surface of tongue,surface of tongue
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
COVID-19 2019 novel coronavirus,2019 novel coronavirus infection,2019-nCoV,2019-nCoV infection,beta-CoV,beta-CoVs,betacoronavirus,coronavirus disease 2019,SARS-coronavirus 2,SARS-CoV-2,severe acute respiratory syndrome coronavirus 2,severe acute respiratory syndrome coronavirus 2 infectious disease,β-coronavirus,β-CoV,β-CoVs,COVID-19,cOVID-19
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Control group
Group 1 name Corresponds to the case (exposed) group for case-control studies
Covid-19 group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group consists of 71 patients with Covid-19.
Group 0 sample size Number of subjects in the control (unexposed) group
132
Group 1 sample size Number of subjects in the case (exposed) group
71
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
8 weeks

Lab analysis

Sequencing type
ITS / ITS2
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
3
Matched on Factors on which subjects have been matched on in a case-control study
age, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Richness Number of species
increased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-6-5

Curated date: 2024/04/19

Curator: Victoria

Revision editor(s): Victoria

Source: Figure 4g

Description: This figure shows the predominant oral fungal among the COVID-19, Post-COVID-19, and control groups.

Abundance in Group 1: increased abundance in Covid-19 group

NCBI Quality ControlLinks
Acrodictys
Acrodictys fluminicola
Angustimassarina
Angustimassarina camporesii
Aspergillus subflavus
Chrysosphaeria
Chrysosphaeria jannelii
Fantasmomyces hyalinus
Hydnobolites
Hydnobolites roseus
Parafuscosporella
Vanakripa mucosa
Parasympodiella
Parasympodiella longispora
Saccharomyces
Saccharomyces cerevisiae
Simplicillium
Simplicillium sympodiophorum
Tuber
Tuber alcaracense
[Cryptococcus] ater
Filobasidiaceae gen Incertae sedisFilobasidiaceae gen Incertae sedis
Candida spe Incertae sedisCandida spe Incertae sedis
Fantasmomyces

Revision editor(s): Victoria

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-6-5

Curated date: 2024/04/19

Curator: Victoria

Revision editor(s): Victoria

Source: Figure 4g

Description: This figure shows the predominant oral fungal among the COVID-19, Post-COVID-19, and control groups.

Abundance in Group 1: decreased abundance in Covid-19 group

NCBI Quality ControlLinks
Zanclospora jonesii
Milospium graphideorum
Diversispora
Zanclospora
Diaporthe
Vanrija longa
Russula xerophila
Talaromyces
Milospium
Aspergillus amstelodami
Diversispora spurca
Cladosporium kenpeggii
Ophiostoma
Raffaelea
Arthrographis grakistii
Russula
Cryptococcus
Blumeria spe Incertae sedisBlumeria spe Incertae sedis
Blumeria
Harringtonia lauricola
Malassezia restricta
Arthrographis
Fungi gen Incertae sedisFungi gen Incertae sedis
Candida parapsilosis
Fungi spe Incertae sedisFungi spe Incertae sedis

Revision editor(s): Victoria

Experiment 2


Reviewed Marked as Reviewed by Svetlana up on 2024-6-5

Curated date: 2024/04/18

Curator: Victoria

Revision editor(s): Victoria

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Covid-19 group
Group 1 name Corresponds to the case (exposed) group for case-control studies
Post-Covid-19 group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group consists of patients who have recovered from Covid-19.
Group 0 sample size Number of subjects in the control (unexposed) group
71
Group 1 sample size Number of subjects in the case (exposed) group
22

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Richness Number of species
decreased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-6-5

Curated date: 2024/04/19

Curator: Victoria

Revision editor(s): Victoria

Source: Figure 4g

Description: This figure shows the predominant oral fungal among the COVID-19, Post-COVID-19, and control groups.

Abundance in Group 1: increased abundance in Post-Covid-19 group

NCBI Quality ControlLinks
Actinomucor
Actinomucor elegans
Aspergillus penicillioides
Botryosphaeria
Candida
Candida albicans
Dipodascus
Galactomyces
Galactomyces pseudocandidus
Geotrichum candidum
Malassezia
Mucor
Mucor circinelloides
Mucor pseudolusitanicus
Rhodotorula
Rhodotorula mucilaginosa
Talaromyces scorteus
Udeniomyces
Udeniomyces megalosporus
Udeniomyces pyricola
Botryosphaeria spe Incertae sedisBotryosphaeria spe Incertae sedis

Revision editor(s): Victoria

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-6-5

Curated date: 2024/04/19

Curator: Victoria

Revision editor(s): Victoria

Source: Figure 4g

Description: This figure shows the predominant oral fungal among the COVID-19, Post-COVID-19, and control groups.

Abundance in Group 1: decreased abundance in Post-Covid-19 group

NCBI Quality ControlLinks
Simplicillium sympodiophorum
Parasympodiella longispora
Chrysosphaeria
Angustimassarina camporesii
Aspergillus subflavus
Chrysosphaeria jannelii
Hydnobolites
[Cryptococcus] ater
Acrodictys
Fantasmomyces hyalinus
Saccharomyces cerevisiae
Parasympodiella
Fantasmomyces
Simplicillium
Acrodictys fluminicola
Saccharomyces
Candida spe incertae sedisCandida spe incertae sedis
Hydnobolites roseus
Filobasidiaceae gen Incertae sedisFilobasidiaceae gen Incertae sedis
Vanakripa mucosa
Tuber
Tuber alcaracense
Parafuscosporella
Entorrhiza
Angustimassarina

Revision editor(s): Victoria

Experiment 3


Reviewed Marked as Reviewed by Svetlana up on 2024-6-5

Curated date: 2024/04/20

Curator: Victoria

Revision editor(s): Victoria

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Control group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group consists of 22 patients who have recovered from Covid-19.
Group 0 sample size Number of subjects in the control (unexposed) group
132

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Richness Number of species
decreased

Signature 1

Needs review

Curated date: 2024/04/24

Curator: Victoria

Revision editor(s): Victoria

Source: Figure 4g

Description: This figure shows the predominant oral fungal among the COVID-19, Post-COVID-19, and control groups.

Abundance in Group 1: increased abundance in Post-Covid-19 group

NCBI Quality ControlLinks
Actinomucor
Actinomucor elegans
Aspergillus penicillioides
Botryosphaeria
Candida
Candida albicans
Dipodascus
Galactomyces
Galactomyces pseudocandidus
Geotrichum candidum
Malassezia
Mucor
Mucor circinelloides
Mucor pseudolusitanicus
Rhodotorula
Rhodotorula mucilaginosa
Talaromyces scorteus
Udeniomyces
Udeniomyces megalosporus
Udeniomyces pyricola
Botryosphaeria spe Incertae sedisBotryosphaeria spe Incertae sedis

Revision editor(s): Victoria

Experiment 4


Reviewed Marked as Reviewed by Svetlana up on 2024-6-5

Curated date: 2024/06/03

Curator: Victoria

Revision editor(s): Victoria

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Covid-19-N group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group consists of 56 Covid-19 patients without comorbidities.
Group 1 sample size Number of subjects in the case (exposed) group
56

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Richness Number of species
increased

Signature 1

Needs review

Curated date: 2024/06/03

Curator: Victoria

Revision editor(s): Victoria

Source: Supplemental Figure S4

Description: The 10 most abundant fungi among the differential fungi among the three groups at the genus and species levels.

Abundance in Group 1: increased abundance in Covid-19-N group

NCBI Quality ControlLinks
Acrodictys
Candida
Hydnobolites
Raffaelea
Harringtonia lauricola
Acrodictys fluminicola
Hydnobolites roseus
Candida albicans

Revision editor(s): Victoria

Signature 2

Needs review

Curated date: 2024/06/03

Curator: Victoria

Revision editor(s): Victoria

Source: Supplemental Figure S4

Description: The 10 most abundant fungi among the differential fungi among the three groups at the genus and species levels

Abundance in Group 1: decreased abundance in Covid-19-N group

NCBI Quality ControlLinks
Zanclospora
Blumeria
Cryptococcus
Cladosporium
Malassezia
Diversispora
Zanclospora jonesii
Blumeria spe Incertae sedisBlumeria spe Incertae sedis
Vanrija longa
Malassezia restricta
Diversispora spurca
Cladosporium kenpeggii

Revision editor(s): Victoria

Experiment 5


Reviewed Marked as Reviewed by Svetlana up on 2024-6-5

Curated date: 2024/06/03

Curator: Victoria

Revision editor(s): Victoria

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Covid-19-C group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group consists of 15 Covid-19 patients with comorbidities.
Group 1 sample size Number of subjects in the case (exposed) group
15

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Richness Number of species
increased

Signature 1

Needs review

Curated date: 2024/06/03

Curator: Victoria

Revision editor(s): Victoria

Source: Supplemental Figure S4

Description: The 10 most abundant fungi among the differential fungi among the three groups at the genus and species levels.

Abundance in Group 1: increased abundance in Covid-19-C group

NCBI Quality ControlLinks
Candida albicans
Candida
Raffaelea
Hydnobolites
Hydnobolites roseus

Revision editor(s): Victoria

Signature 2

Needs review

Curated date: 2024/06/03

Curator: Victoria

Revision editor(s): Victoria

Source: Supplemental Figure S4

Description: The 10 most abundant fungi among the differential fungi among the three groups at the genus and species levels.

Abundance in Group 1: decreased abundance in Covid-19-C group

NCBI Quality ControlLinks
Zanclospora
Cryptococcus
Diversispora
Zanclospora jonesii
Diversispora spurca
Vanrija longa

Revision editor(s): Victoria

Experiment 6


Reviewed Marked as Reviewed by Svetlana up on 2024-6-5

Curated date: 2024/06/03

Curator: Victoria

Revision editor(s): Victoria

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Covid-19-N group
Group 0 sample size Number of subjects in the control (unexposed) group
56

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Richness Number of species
unchanged

Signature 1

Needs review

Curated date: 2024/06/03

Curator: Victoria

Revision editor(s): Victoria

Source: Supplemental Figure S4

Description: The 10 most abundant fungi among the differential fungi among the three groups at the genus and species levels.

Abundance in Group 1: increased abundance in Covid-19-C group

NCBI Quality ControlLinks
Blumeria
Blumeria spe Incertae sedisBlumeria spe Incertae sedis

Revision editor(s): Victoria